Post-coital gross hematuria: an unusual presentation of benign prostatic hyperplasia.
OBJECTIVE
To describe an unusual symptom of benign prostatic hyperplasia (BPH).


METHODS
A patient presented to our urology clinic having experienced post-coital gross hematuria for 2 years. He had not experienced lower urinary tract symptoms (LUTS). A series of examinations were performed to determine the source of bleeding.


RESULTS
The prostate was defined as the active bleeding source responsible for the patient's post-coital hematuria. Endoscopic fulguration did not alleviate the symptom. The use of dutasteride, a dual inhibitor of 5alpha-reductase, solved the problem.


CONCLUSIONS
This study reports for the first time that post-coital gross hematuria is one of the clinical presentations of BPH, which can be successfully treated with 5alpha-reductase inhibitor.
Chen
Yi-Hong
YH
Department of Urology, College of Medicine, National Cheng Kung University, Tainan, Taiwan 704, China.
Lin
Pei-Yu
PY
Cheng
Yu-Sheng
YS
Lin
Johnny Shinn-Nan
JS
Lin
Yung-Ming
YM
D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids / Q000627:therapeutic use; D003075:Coitus / Q000502:physiology*; D000068538:Dutasteride; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006417:Hematuria / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D014551:Urinary Tract
D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D004791:Enzyme Inhibitors; D000068538:Dutasteride